ACKERMAN JOEL 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
ACKERMAN JOEL
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Option to purchase Common Stock
2025-10-30$2.10/sh−94,405$198,251→ 0 totalExercise: $2.10Exp: 2025-11-01→ Common Stock (94,405 underlying) - Exercise/Conversion
Common Stock
2025-10-30$2.10/sh+94,405$198,251→ 1,056,539 total
Footnotes (1)
- [F1]70,804 options were immediately exercisable on grant date of July 19, 2016, with the remaining options vesting and available to exercise on October 31, 2016.